Endocrinology
Clinical
Aspirin shows little benefit for primary prevention of vascular disease in diabetes
Is aspirin for primary prevention of cardiovascular events in patients with diabetes worth the risk of adverse bleeding events?
News
SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF
NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart...
Clinical
Statin exposure associated with idiopathic inflammatory myositis
What is the association between exposure to statin medications and histologically confirmed idiopathic inflammatory myositis?
News
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.
News
Subclinical hypothyroidism boosts immediate risk of heart failure
CHICAGO – Large Danish study links subclinical and overt hypothyroidism to immediate risk of heart failure.
News
SGLT-2 inhibitors promising for heart failure prevention, not treatment
LOS ANGELES – The combination of heart failure and diabetes is particularly lethal.
News
New diabetes drugs solidify their cardiovascular and renal benefits
CHICAGO –
News
Nasal glucagon ‘viable alternative’ to intramuscular administration
BERLIN – Severe hypoglycemia was reversed successfully in all patients with type 1 diabetes mellitus given nasal glucagon.
Clinical
Transforming glycemic control at Norwalk Hospital
Norwalk Hospital created a Glycemic Care Team to focus on improving the quality of care for inpatients with diabetes.
Clinical
Perioperative diabetes and HbA1c in mortality
Do preoperative hemoglobin A1c (HbA1c) and perioperative glucose predict outcomes in patients undergoing noncardiac and...